INFLUX

What Influx Healthtech promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q4 FY26

what the last two calls moved 13 tracked 1 delivered 2 missed 10 open
  • Regulatory Approvals delivered said Q2 FY26 Promised: Tanzania audit on Dec 11 Q4 FY26: Management confirmed in the detailed narrative that 'regulatory approvals secured in Tanzania and Nigeria', successfully completing this objective.
  • Revenue missed said Q2 FY26 Promised: INR 150+ crores in FY26 Q4 FY26: Company reported full-year FY26 revenue of INR 146 crores, slightly missing the guided target of INR 150+ crores.
  • Revenue at risk said Q2 FY26 Promised: Double the business by FY27 Q4 FY26: FY26 revenue closed at INR 146 Cr. Management's FY27 growth guidance of 25-30% (to ~INR 183-190 Cr) is not on a trajectory to double the FY25 base (~INR 105 Cr) by FY27.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 13 tracked commitments for Influx Healthtech — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens